FaunaBio
Katharine Grabek has worked as the CSO at FaunaBio since September 2018. Prior to this, they were a Postdoctoral Scholar at Stanford University from July 2014 to September 2018. Katharine also worked as a Graduate Research Assistant at the University of Colorado from August 2008 to May 2014, and as a Graduate Research Assistant at Plymouth State University from June 2006 to August 2008.
Katharine Grabek pursued their education in the field of genetics and medical biology. Katharine completed their Bachelor of Science (B.S.) in Biotechnology from Plymouth State University in the years 2004 to 2006. Following this, they obtained a Master of Science (MS) degree in Biology from the same institution from 2006 to 2008. Finally, Katharine furthered their education by completing a Doctor of Philosophy (Ph.D.) in Human/Medical Genetics from the University of Colorado Anschutz Medical Campus, where they were enrolled from 2008 to 2014.
This person is not in any teams
FaunaBio
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bioleverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.